Evidence map›Paper›PMID 19058272›Full record

ReviewChembiochem : a European journal of chemical biology2009

How nature morphs peptide scaffolds into antibiotics.

Elizabeth M Nolan, Christopher T Walsh

Open access · greenAbstract readReview
In one paragraph

Review in Chembiochem : a European journal of chemical biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 106 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Elizabeth M NolanDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Christopher T Walsh
Harvard University · US

Funding

Modular Enzymatic Assembly Lines for AntibioticsR01GM020011 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WALSH, CHRISTOPHER T · 1985 to 2013
$8.2M
The Vancomycin Biosynthetic Assembly lineR01GM049338 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALSH, CHRISTOPHER T · 1993 to 2012
$6.2M
5S RRNA RECOGNITION BY TRANSCRIPTION FACTOR IIIAF32GM020011 · NIGMS · SCRIPPS RESEARCH INSTITUTE · PI LEE, BRIAN M · 1999 to 2000
$39k
ENZYMATIC REACTION MECHANISMSR37GM020011 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WALSH, CHRISTOPHER A · 1986 to 1995
–
NIGMS NIH HHS F32 GM020011NIGMS NIH HHS GM 20011NIGMS NIH HHS GM 49338NIGMS NIH HHS R01 GM020011NIGMS NIH HHS R01 GM049338
6 · The paper itself

Abstract

The conventional notion that peptides are poor candidates for orally available drugs because of protease-sensitive peptide bonds, intrinsic hydrophilicity, and ionic charges contrasts with the diversity of antibiotic natural products with peptide-based frameworks that are synthesized and utilized by Nature. Several of these antibiotics, including penicillin and vancomycin, are employed to treat bacterial infections in humans and have been best-selling therapeutics for decades. Others might provide new platforms for the design of novel therapeutics to combat emerging antibiotic-resistant bacterial pathogens.

Indexed as

AnimalsAnti-Bacterial AgentsBiological ProductsHumansPeptidesRibosomal ProteinsAnti-Bacterial AgentsBiological ProductsPeptidesRibosomal Proteins

Identifiers

PMID19058272
PMCPMC2846400
OpenAlexW1976579934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.